Literature DB >> 2385155

Spontaneous reactivation of hepatitis B virus infection in patients with chronic type B hepatitis.

G Fattovich1, L Brollo, A Alberti, G Realdi, P Pontisso, G Giustina, A Ruol.   

Abstract

Eighty-eight consecutive hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) positive, heterosexual patients of Caucasian origin presenting with chronic hepatitis were followed for 1 to 15 years (mean, 5.4 years). During the study period, 45 (51%) patients cleared HBeAg and hepatitis B virus-deoxyribonucleic acid from serum and were followed for 53 +/- 29 months (mean +/- SD) after seroconversion to antibody to hepatitis B e antigen. All patients manifested biochemical improvement. During follow-up, 10 (22%) of the 45 patients experienced spontaneous reactivation of hepatitis B replication with reappearance of serum hepatitis B virus-deoxyribonucleic acid and, in 4 patients, of hepatitis B e antigen. All patients then showed biochemical exacerbation of disease. These serologic events were transient, lasting an average of 12 months, in 8 (80%) patients. All patients were asymptomatic or minimally symptomatic. Histologic findings of liver tissue from 7 patients showed progression from chronic active hepatitis to active cirrhosis in 2 (28%) patients, while in the remaining 6 cases histology remained unchanged or improved from chronic active to chronic persistent hepatitis. These data indicate that spontaneous reactivation of hepatitis B infection occurs in heterosexual patients with chronic hepatitis B and this event is usually transient and asymptomatic, although in some patients it may be the major cause of progressive hepatic damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2385155     DOI: 10.1111/j.1600-0676.1990.tb00449.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  4 in total

1.  Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection.

Authors:  Kazumoto Murata; Kazushi Sugimoto; Katsuya Shiraki; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

2.  Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients.

Authors:  Sylvia Brost; Paul Schnitzler; Wolfgang Stremmel; Christoph Eisenbach
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

Review 3.  Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment.

Authors:  Sagarika Shahriar; Yusha Araf; Rasel Ahmad; Pravakar Kattel; Ganga Sagar Sah; Tanjim Ishraq Rahaman; Rahila Zannat Sadiea; Shahnaj Sultana; Md Sayeedul Islam; Chunfu Zheng; Md Golzar Hossain
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

4.  Hepatitis B Virus Inactive Carriers: Which Follow-up Strategy?

Authors:  Maria João Magalhães; Isabel Pedroto
Journal:  GE Port J Gastroenterol       Date:  2015-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.